Will Beyond Air stock go up?

According to Danelfin AI, Beyond Air has today an AI Score of 3/10 (Sell rating), because its probability of beating the market in 3 months (44.35%) is -6.47% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Beyond Air stock?

The Beyond Air target price is $0.47 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Beyond Air stock right now?

Beyond Air has today a Sell rating (AI Score 3/10), according to Danelfin AI. Its probability of beating the market in 3 months (44.35%) is -6.47% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Beyond Air stock is a good buy .

Is Beyond Air undervalued right now?

Based on analysts, the average price target downside for Beyond Air is 0.00% (1Y). According to Danelfin AI, Beyond Air has today an AI Score of 3/10 (Sell Rating).

What was the price range of Beyond Air stock over the past 12 months?

The Beyond Air stock price range over the past 12 months has been $0.35 - $4.64.

What is going on with Beyond Air stock in the last 3 months?

The Beyond Air stock performance in the last quarter has been -34.33%.

Does Beyond Air offer dividend payments?

No, Beyond Air does not currently pay dividends.

What is the current market capitalization of Beyond Air?

Beyond Air's market cap is $6.74M, as of 2026-07-03 08:00.

Beyond Air Inc (XAIR) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

XAIR AI-Powered Stock Analysis

AI Score Explanation

AI Score

Sell

Fundamental
Technical
Sentiment
Low Risk

According to Danelfin’s proprietary AI model, Beyond Air Inc today receives an AI Score of 3/10, which translates to a Sell rating. The stock has a 44% probability of outperforming the market in the next 3 months, which is 7% lower than the average probability of any stock (51%). The top positive contributors include the Chart Pattern (180d) (+2.04%), Technicals Impact (Long Tail) (+1.98%), ATR (14d Volatility) (+1.43%), Performance (YTD) (+0.98%), and Earnings Countdown (+0.81%). On the negative side, the top detractors are the Chart Pattern (504d) (-2.75%), Industry (GICS) (-2.16%), Chart Pattern (252d) (-1.91%), Basic EPS Consolidated (-1.82%), and Fear & Greed Index (CNN) (-1.45%). Notable data points include Basic EPS Consolidated in the bottom 10% with a value of -4.14, indicating weak profitability, and Operating Profit Margin also in the bottom 10% at -378.23%, reflecting severe operational inefficiency. On the positive side, ATR (14d Volatility) is in the bottom 10%, suggesting low volatility, and Performance (YTD) is in the bottom 20% with a -35.4% return, which historically can signal a rebound potential. However, the overall picture is bearish: the stock’s probability of outperforming is below average, weighed down by poor fundamentals and negative chart patterns, justifying the Sell rating.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Volatility+1.14%
How much the stock price tends to fluctuate
Momentum+0.61%
Direction and strength of recent price movements

Sentiment-3.47%
How analysts and the market view the stock
Growth-1.82%
Expected pace of revenue and earnings expansion
Valuation-1.42%
How the stock is priced relative to its fundamentals
Size & Liquidity-0.81%
Company size and trading liquidity
Profitability-0.71%
Profitability and operating efficiency metrics

XAIR probability advantage of beating the market (3M):

-6.47%

AI Score

Sell

Beyond Air (XAIR) has an AI Score of 3/10 (Sell) because, according to an overall analysis, it has a probability advantage of -6.47% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of XAIR (44.35%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
XAIR probability advantage of beating the market (3M)-6.47%
XAIR probability of beating the market (3M)44.35%

XAIR probability advantage of beating the market (3M): -6.47%

The AI-powered overall analysis of Beyond Air (XAIR) is based on the 27 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of XAIR:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Technical	Chart Pattern (504d)	figure_24	N/A	-2.75%
Sentiment	Industry (GICS)	Health Care Equipment & Supplies	N/A	-2.16%
Technical	Chart Pattern (180d)	figure_21	N/A	+2.04%
Technical	Technicals Impact (Long Tail)	-	N/A	+1.98%
Technical	Chart Pattern (252d)	figure_8	N/A	-1.91%
Fundamental	Basic EPS Consolidated	-4.14	N/A	-1.82%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-1.45%
Technical	ATR (14d Volatility)	0.05	N/A	+1.43%
Technical	Performance (YTD)	-0.35%		+0.98%
Technical	Maximum Volatility	15.82%		-0.81%
Sentiment	Upgrade to unlock			+0.81%
Fundamental	Upgrade to unlock			-0.81%
Fundamental	Upgrade to unlock			-0.72%
Fundamental	Upgrade to unlock			-0.71%
Sentiment	Upgrade to unlock			-0.64%

Rest of Alpha Signals: +0.07%

XAIR probability advantage of beating the market (3M)Total:-6.47%
XAIR AI Score

Significant changes Vs previous day

XAIR Short Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$0.47
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro)
Take Profit:$XXXXXPro (XXXXX
Pro
)

XAIR Proven Sell Signal & Price Forecast

This is the price chart for XAIR from January 2, 2026 until today. The chart indicates, in red, the 87 days when the stock received a Sell/Strong Sell rating (sell signals, AI Score 1 to 3).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Sell signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Sell signals

Forecast:

1 Month
3 Months
6 Months
1 Year

XAIR Average Past Performance & Loss Rate

Three months after its 776 Sell signals since July 2026, XAIR had an average performance of xxxxxx and a xxxxxx Loss rate (negative performance).

776 Past XAIR Sell Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				-11.15%
Average Alpha				-20.44%
Loss Rate (% Negative Perf.)				61.66%
% Negative Alpha				64.48%

XAIR Frequently Asked Questions

Will Beyond Air stock go up?
According to Danelfin AI, Beyond Air has today an AI Score of 3/10 (Sell rating), because its probability of beating the market in 3 months (44.35%) is -6.47% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Beyond Air stock?
Is it a good time to buy, sell, or hold Beyond Air stock right now?
Is Beyond Air undervalued right now?
What was the price range of Beyond Air stock over the past 12 months?
What is going on with Beyond Air stock in the last 3 months?
Does Beyond Air offer dividend payments?
What is the current market capitalization of Beyond Air?

Beyond Air Inc Company Profile

Beyond Air, Inc. functions as an advanced-stage medical apparatus and biopharmaceutical corporation rooted in the United States. It commits to the evolution of its flagship LungFit platform, which serves as a cutting-edge generator and dispensing system for nitric oxide. Amongst its portfolio offerings, LungFit PH commands attention for its expertly devised treatment approach towards managing persistent pulmonary hypertension uniquely evident in newborns.

Further enhancing its product range, Beyond Air taps into urgent healthcare needs by creating LungFit PRO, an innovative solution aimed at bringing relief to viral lung infections. This sphere encompasses community-acquired viral pneumonia and even reaches into tackling novel illnesses such as COVID-19. Additionally, it strategizes a specialized approach to treating bronchiolitis in hospitalized patients.

Also nestling within its development pipeline is LungFit GO; strategized with precision for dealing with nontuberculous mycobacteria, these initiatives reflect Beyond Air's expansive view of respiratory care solutions

Established originally under the banner AIT Therapeutics, Inc., 2019 saw it rebranding itself as Beyond Air, sharpening focus on leading-edge respiratory solutions. Today, Beyond Air finds its grounding firmly planted in Garden City, New York: reflecting its growth and continued commitment to pioneering medical advancements.

Sector:
Country:United States
Industry:
Address:900 Stewart Ave, Suite 301, Garden City
Employees:61
Website:beyondair.net

Pros

On-site nitric oxide generation capability

Proprietary technology for gas delivery

Potential for multiple therapeutic indications

Recurring revenue from system consumables

Reduced reliance on compressed gas supply chain

Cons

Extensive regulatory approval pathways for new indications

High capital expenditure for clinical development

Market penetration challenges against incumbent therapies

Uncertainty in securing favorable reimbursement coverage

Competition from established medical gas providers

Company	AI Score	Compare
LUNGPulmonx Corp
NYXHNyxoah SA
LIVNLivaNova PLC
ADVBAdvanced Biomed Inc

Company	AI Score	Compare
LUNGPulmonx Corp
NYXHNyxoah SA
LIVNLivaNova PLC
ADVBAdvanced Biomed Inc

XAIR Stock AI Analysis

Beyond Air Inc

XAIR Stock AI Analysis

Beyond Air Inc

XAIR AI-Powered Stock Analysis

AI Score Explanation

AI Score Explanation

Generating AI Score explanation

AI Score Alpha Factors

Alpha Signals: What Drives the AI Score

XAIR probability advantage of beating the market (3M): -6.47%

XAIR Short Trading Parameters

XAIR Proven Sell Signal & Price Forecast

XAIR Average Past Performance & Loss Rate

XAIR Frequently Asked Questions

Will Beyond Air stock go up?

What is the target price for Beyond Air stock?

Is it a good time to buy, sell, or hold Beyond Air stock right now?

Is Beyond Air undervalued right now?

What was the price range of Beyond Air stock over the past 12 months?

What is going on with Beyond Air stock in the last 3 months?

Does Beyond Air offer dividend payments?

What is the current market capitalization of Beyond Air?

Beyond Air Inc Company Profile

Pros

Cons

Pros

Cons

XAIR Company Profile Summary

XAIR Related Investment Themes

XAIR Related Stocks

XAIR Top 10 Industry Stocks

Health Care Equipment & Supplies

XAIR Top 10 Sector Stocks

Health Care

XAIR Stock AI Analysis

Beyond Air Inc

NASDAQ NMS - GLOBAL MARKET

Will Beyond Air stock go up?

What is the target price for Beyond Air stock?

Is it a good time to buy, sell, or hold Beyond Air stock right now?

Is Beyond Air undervalued right now?

What was the price range of Beyond Air stock over the past 12 months?

What is going on with Beyond Air stock in the last 3 months?

Does Beyond Air offer dividend payments?

What is the current market capitalization of Beyond Air?

NASDAQ NMS - GLOBAL MARKET

XAIR Proven Sell Signal & Price Forecast

Pros

Cons

AI Score Explanation